The diagnostic study determined, in a real-life clinical setting, for whom diagnostic Aß imaging ws appropriate, when this was best performed and how the resulting information was influencing diagnostic thinking, patient management and ultimately decision trees and cost-effectiveness of dementia care.

Objective:
AMYPAD selected and followed up a memory clinic population investigated for memory complaints or possible AD. Patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI) and dementia possibly due to AD but with unclear aetiology were studied to estimate the impact of β-amyloid imaging on change of diagnosis, diagnostic confidence, treatment decisions, and management changes.